Business / Finance

RSS

PlanSource expands strategic relationship with Aetna

PlanSource, a cloud-based, on-demand technology company that provides state-of-the-art benefits administration, exchange, payroll, and HRIS solutions to employers through insurance carriers and brokers, has announced that it is expanding its strategic relationship with Aetna into three new states: Georgia, North Carolina, and Tennessee.

6 Jun 2013

CytomX collaborates with Pfizer to develop, commercialize more effective antibody-drug conjugates

CytomX Therapeutics, Inc., a biotechnology company developing a new generation of targeted antibody therapeutics, today announced that it has entered into a global strategic collaboration with Pfizer Inc. to develop and commercialize multiple Probody-Drug Conjugates.

6 Jun 2013

Comprehensive Care Corporation enters into agreement with leading healthcare consulting firm

Comprehensive Care Corporation, a leading behavioral health, substance abuse and pharmacy management provider for employers, Taft-Hartley health and welfare funds, and managed care companies, today announced that it has entered into an agreement with Upstate Financial Service/ John Argiro (collectively, "Mr. Argiro"), a leading consulting firm in healthcare to local and national unions, municipalities and private-sector groups.

4 Jun 2013

Allenex to sell its holding in AnaMar AB to Koncentra Holding

Allenex has agreed to sell its holding in AnaMar AB to the company's main owner Koncentra Holding. The price is set to 1,7 mkr. Allenex became an owner in AnaMar 1998.

3 Jun 2013

Arcturus Therapeutics closes $1.3 M in seed funding round

Arcturus Therapeutics, Inc., an industry leader in RNAi technologies for the treatment of disease, today announced it has raised $1.3 million in a seed funding round led by multiple high net-worth private investors from the United States and Canada.

3 Jun 2013

Ohr Pharmaceutical declares 1-for-3 reverse split of its outstanding common stock

Ohr Pharmaceutical, Inc. (OTCQB: OHRP), a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs, today announced a 1-for-3 reverse split of the Company's issued and outstanding common stock. The reverse stock split will be effective prior to the stock market opening on Monday, June 3, 2013.

3 Jun 2013

Activ8rlives 2.0 goes live with new self monitoring capabilities for health and wellness

Activ8rlives’ website version 2.0 has now gone live after several months of preparation and testing. Activ8rlives focuses its online self monitoring solutions for health and wellness, which is utilized by families, groups and companies.

3 Jun 2013

NYSE MKT to continue CorMedix's listing

CorMedix Inc. ("CorMedix") (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal disease, has received a notice from the NYSE MKT that CorMedix made reasonable demonstration of its ability to regain compliance with Section 1003(a)(i) of the NYSE MKT Company Guide ("Company Guide") by October 20, 2013.

1 Jun 2013

WebToMed forms strategic partnership with BioTE Medical

BioTE Medical COO Dan DeNeui today announced a strategic partnership with WebToMed, a Chicago based digital medical marketing firm. BioTE Medical is a leading provider of bio-identical hormone pellet therapy.

1 Jun 2013

Arrow officially approved by France Ministry of Health for hosting of health data

The Asplenium business of Arrow Electronics Inc. has been officially approved by the France Ministry of Health to the highest level of certification for the hosting of health data.

1 Jun 2013

Teh Seng’s generic Lidoderm manufacturing facility in Taiwan successfully completes FDA cGMP audit

TWi Pharmaceuticals, Inc., today announced that Teh Seng Pharmaceutical Mfg. Co., the manufacturing partner for its generic version of Lidoderm (5% lidocaine patch) located in Taiwan, has completed the cGMP audit and pre-approval inspection by US Food and Drug Administration and been granted "acceptable" status under the FDA's regulatory guidelines.

29 May 2013

NWI REIT delivers strong first quarter results

NorthWest International Healthcare Properties REIT announced today that it has released its results for the three month period ended March 31, 2013.

28 May 2013

Omthera to be acquired by AstraZeneca

AstraZeneca today announced that it has entered into a definitive agreement to acquire Omthera Pharmaceuticals, a specialty pharmaceutical company based in Princeton, New Jersey, focused on the development and commercialization of new therapies for abnormal levels of lipids in the blood, referred to as dyslipidemia.

28 May 2013

Nepstar’s first quarter revenue increases to RMB627.4 million

China Nepstar Chain Drugstore Ltd., the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the first quarter ended March 31, 2013.

28 May 2013

New deal to bring Mendor's all-in-one blood glucose monitoring system to nine European markets

Mendor, the Finnish diabetes technology company, is proud to announce its partnership with A. Menarini Diagnostics S.r.l, one of Europe's leading diagnostics companies in the field of diabetes.

28 May 2013

New analysis shows Chinese Pharmaceutical Market revenues to more than double by 2016

Rising incomes, improving healthcare infrastructure, and enhanced insurance systems have propelled the Chinese pharmaceutical market to become the third-largest in the world.

28 May 2013

Innovative nebulizer to treat cystic fibrosis developed by Cambridge Consultants

Observing surfers with cystic fibrosis (CF) led scientists to discover that the inhaled mist of seawater has a therapeutic effect on the lung problems associated with the disease. Now the findings have been used by pharmaceutical company Parion Sciences and product development firm Cambridge Consultants in a revolutionary new aerosol delivery system. It enables CF sufferers to get the benefits of saltwater treatment in their own homes overnight while they sleep.

23 May 2013

Video demonstrating a SPE microplate method for reproducible isolation of high quality RNA released by INTEGRA

INTEGRA has released a new video demonstrating a solid phase extraction (SPE) microplate method for reproducible, high throughput isolation of high-quality DNA-free total RNA.

From INTEGRA Biosciences 22 May 2013

HI VISION™ Preirus™ ultrasound scanner released by PENTAX Medical

PENTAX Medical Company, a healthcare industry leader in endoscopic imaging, recently announced the release of the HI VISION™ Preirus™ ultrasound scanner. PENTAX Medical, in collaboration with Hitachi-Aloka, has had a rich history of introducing ultrasound scanners to the gastroenterology and pulmonary markets that present new possibilities in imaging capabilities. The new, state-of-the-art HI VISION™ Preirus will continue this tradition, enabling better patient care.

From PENTAX Medical Company 22 May 2013

Grifols signs worldwide licensing agreement for Aradigm's Pulmaquin

Grifols, S.A. and Aradigm Corporation today announced the signing of an exclusive, worldwide license for Aradigm's proprietary formulations of inhaled ciprofloxacin (Pulmaquin and Lipoquin) for the treatment of severe respiratory diseases, including non-cystic fibrosis bronchiectasis.

21 May 2013

Business / Finance

PlanSource expands strategic relationship with Aetna

CytomX collaborates with Pfizer to develop, commercialize more effective antibody-drug conjugates

Comprehensive Care Corporation enters into agreement with leading healthcare consulting firm

Allenex to sell its holding in AnaMar AB to Koncentra Holding

Arcturus Therapeutics closes $1.3 M in seed funding round

Ohr Pharmaceutical declares 1-for-3 reverse split of its outstanding common stock

Activ8rlives 2.0 goes live with new self monitoring capabilities for health and wellness

NYSE MKT to continue CorMedix's listing

WebToMed forms strategic partnership with BioTE Medical

Arrow officially approved by France Ministry of Health for hosting of health data

Teh Seng’s generic Lidoderm manufacturing facility in Taiwan successfully completes FDA cGMP audit

NWI REIT delivers strong first quarter results

Omthera to be acquired by AstraZeneca

Nepstar’s first quarter revenue increases to RMB627.4 million

New deal to bring Mendor's all-in-one blood glucose monitoring system to nine European markets

New analysis shows Chinese Pharmaceutical Market revenues to more than double by 2016

Innovative nebulizer to treat cystic fibrosis developed by Cambridge Consultants

Video demonstrating a SPE microplate method for reproducible isolation of high quality RNA released by INTEGRA

HI VISION™ Preirus™ ultrasound scanner released by PENTAX Medical

Grifols signs worldwide licensing agreement for Aradigm's Pulmaquin

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Latest News